Fulgent Genetics, Inc. (FLGT) vs MiMedx Group, Inc. (MDXG)
A side-by-side comparison of Fulgent Genetics, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FLGT
Fulgent Genetics, Inc.
$20.90HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
MDXG
MiMedx Group, Inc.
$4.60HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — FLGT vs MDXG
growth of $100 · dividends reinvested · last 10yFLGT +130.1% (+8.7%/yr)MDXG -48.5% (-6.4%/yr)FLGT compounded faster over this window
FLGT MDXG
FLGT vs MDXG: by the numbers
- •MDXG is the larger company ($670M vs $594M market cap).
- •MDXG is profitable (1.76% net margin) while FLGT runs a net loss (-26.05%).
- •MDXG grew revenue faster over the past five years (6.36% vs -18.66% CAGR).
Metrics side by side
Valuation
| Metric | FLGT | MDXG |
|---|---|---|
| P/E ratio | N/A | 114.88 |
| P/S ratio | 1.83 | 1.89 |
| P/B ratio | 0.59 | 3.10 |
| EV / EBITDA | N/A | 26.24 |
| FCF yield | N/A | 6.06% |
Profitability
| Metric | FLGT | MDXG |
|---|---|---|
| Gross margin | 35.58% | 78.85% |
| Operating margin | -28.23% | 15.26% |
| Net margin | -26.05% | 1.76% |
| ROE | -8.42% | 2.89% |
| ROIC | -11.80% | 1.97% |
Growth (annualized)
| Metric | FLGT | MDXG |
|---|---|---|
| Revenue CAGR (5Y) | -18.66% | 6.36% |
| Total return CAGR (5Y) | -22.38% | -4.94% |
Frequently asked
- Which has grown faster, FLGT or MDXG?
- Over the past five years, MDXG grew revenue faster — FLGT at a -18.66% CAGR versus MDXG at 6.36%.
- Is FLGT or MDXG more profitable?
- MDXG runs the higher net margin — FLGT at -26.05% versus MDXG at 1.76%.
- How have FLGT and MDXG total returns compared?
- Over the past 10 years, FLGT delivered 8.90% and MDXG delivered -6.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MiMedx P/E ratioFulgent Genetics ROEMiMedx ROEFulgent Genetics operating marginMiMedx operating marginFulgent Genetics revenue growthMiMedx revenue growthFulgent Genetics free cash flowMiMedx free cash flow
Fulgent Genetics & MiMedx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.